MeiraGTx Holdings (MGTX) Accounts Payables (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Accounts Payables of $10.1 million for Q4 2025, down 53.26% on a QoQ basis from $21.5 million in Q3 2025, and down 57.32% year-over-year from $23.6 million in Q4 2024.
MeiraGTx Holdings (MGTX) Accounts Payables (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Accounts Payables history runs 9 years deep, the most recent figure standing at $10.1 million for Q4 2025.
- Quarterly Accounts Payables fell 57.32% year-over-year to $10.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.1 million (down 57.32% YoY) and the FY2025 annual result came in at $10.1 million, down 57.32% from the prior year.
- Accounts Payables was $10.1 million for Q4 2025 at MeiraGTx Holdings, down from $21.5 million in the prior quarter.
- Across five years, Accounts Payables topped out at $29.8 million in Q1 2023 and bottomed at $7.9 million in Q1 2021.
- A 5-year average of $19.5 million and a median of $20.5 million in 2023 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2021 — Accounts Payables surged 276.91% — and 2025, when it tumbled 57.32%.
- MeiraGTx Holdings' Accounts Payables stood at $15.3 million in 2021, then advanced by 8.26% to $16.6 million in 2022, then dropped by 3.45% to $16.0 million in 2023, then surged by 47.03% to $23.6 million in 2024, then tumbled by 57.32% to $10.1 million in 2025.
- Business Quant data shows MGTX's Accounts Payables at $10.1 million in Q4 2025, $21.5 million in Q3 2025, and $25.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 10.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.07 Mn |
| Sep 30, 2025 | 21.54 Mn |
| Jun 30, 2025 | 25.59 Mn |
| Mar 31, 2025 | 20.29 Mn |
| Dec 31, 2024 | 23.59 Mn |
| Sep 30, 2024 | 29.50 Mn |
| Jun 30, 2024 | 21.40 Mn |
| Mar 31, 2024 | 21.22 Mn |
| Dec 31, 2023 | 16.04 Mn |
| Sep 30, 2023 | 20.77 Mn |
| Jun 30, 2023 | 28.50 Mn |
| Mar 31, 2023 | 29.76 Mn |
| Dec 31, 2022 | 16.62 Mn |
| Sep 30, 2022 | 21.69 Mn |
| Jun 30, 2022 | 18.11 Mn |
| Mar 31, 2022 | 18.50 Mn |
| Dec 31, 2021 | 15.35 Mn |
| Sep 30, 2021 | 11.42 Mn |
| Jun 30, 2021 | 11.64 Mn |
| Mar 31, 2021 | 7.90 Mn |